FOXO3 and chronic obstructive pulmonary disease: In summary, these findings indicate that SRT2104 may counteract AECII aging or enhance their repair via the SIRT1/FoxO3a and SIRT1/p53 pathways, offering a potential avenue to slow COPD progression and a new therapeutic strategy for its management.